As of 2026-10-07, the Relative Valuation of Bioventus Inc (BVS) is 13.09 USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.10 USD, the upside of Bioventus Inc based on Relative Valuation is -0.0%.
The range of the Relative Valuation is 11.88 - 14.69 USD.
| Range | Selected | |
| Trailing P/E multiples | 36.3x - 44.9x | 40.0x |
| Forward P/E multiples | 32.1x - 35.3x | 34.3x |
| Fair Price | 11.88 - 14.69 | 13.09 |
| Upside | -9.3% - 12.1% | -0.0% |
| Date | P/E |
| 2026-10-06 | 40.05 |
| 2026-10-05 | 41.33 |
| 2026-10-02 | 40.14 |
| 2026-10-01 | 41.12 |
| 2026-09-30 | 41.67 |
| 2026-09-29 | 42.80 |
| 2026-09-28 | 42.86 |
| 2026-09-25 | 42.22 |
| 2026-09-24 | 41.33 |
| 2026-09-23 | 41.61 |
| 2026-09-22 | 41.73 |
| 2026-09-21 | 40.69 |
| 2026-09-18 | 39.47 |
| 2026-09-17 | 38.61 |
| 2026-09-16 | 40.35 |
| 2026-09-15 | 39.74 |
| 2026-09-14 | 40.23 |
| 2026-09-11 | 39.68 |
| 2026-09-10 | 39.92 |
| 2026-09-09 | 41.67 |
| 2026-09-08 | 42.28 |
| 2026-09-04 | 43.01 |
| 2026-09-03 | 43.90 |
| 2026-09-02 | 43.93 |
| 2026-09-01 | 41.79 |
| 2026-08-31 | 41.73 |
| 2026-08-28 | 42.31 |
| 2026-08-27 | 42.16 |
| 2026-08-26 | 42.71 |
| 2026-08-25 | 43.04 |
| 2026-08-24 | 42.86 |
| 2026-08-21 | 43.96 |
| 2026-08-20 | 43.81 |
| 2026-08-19 | 44.88 |
| 2026-08-18 | 43.72 |
| 2026-08-17 | 42.43 |
| 2026-08-14 | 43.59 |
| 2026-08-13 | 42.46 |
| 2026-08-12 | 42.54 |
| 2026-08-11 | 42.34 |
| 2026-08-10 | 42.68 |
| 2026-08-07 | 43.18 |
| 2026-08-06 | 42.74 |
| 2026-08-05 | 46.65 |
| 2026-08-04 | 41.02 |
| 2026-08-03 | 41.18 |
| 2026-07-31 | 40.26 |
| 2026-07-30 | 40.29 |
| 2026-07-29 | 40.11 |
| 2026-07-28 | 40.38 |